Skip to main content
Atrás
Watch Compare

NewcelX Ltd.

Calidad de datos: 83%
NCEL
Nasdaq Manufacturing Chemicals
$2.49
▲ $0.40 (19.14%)
Cap. Mercado: 9.57 M
Precio
$2.10
Cap. Mercado
9.57 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -4.82 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current RatioN/A
Interest Coverage-131.47

Valoración

PE (TTM)
-4.42
Below sector avg (-1.48)
P/B Ratio3.32
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -4.4 -1.5
P/B 3.3 1.6
ROE % — -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -2.17 M
ROE N/A ROA -78.31%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -4.82 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage -131.47 Asset Turnover N/A
Working Capital N/A Tangible Book Value 2.88 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.42 Forward P/E N/A
P/B Ratio 3.32 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -50.30%
Market Cap 9.57 M Enterprise Value 6.50 M
Per Share
EPS (Diluted TTM) -1.74 Revenue / Share N/A
FCF / Share -1.06 OCF / Share -1.06
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 222.34%
SBC-Adj. FCF -4.92 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -1.98 M -12.17 M -16.50 M -11.95 M -2.86 M
EPS (Diluted) -2.63 -0.32 -0.84 — —
Gross Profit — — — — —
Operating Income -4.38 M -11.81 M -15.48 M -11.86 M -2.30 M
EBITDA — — — — —
R&D Expenses 422,051.0 5.91 M 8.98 M 5.92 M 99,580.0
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 45,054.0 119,920.0 95,211.0 48,100.0 86,792.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 2.23 M 1.85 M 9.28 M 5.76 M 1.21 M
Total Liabilities 826,764.0 10.68 M 6.00 M 5.22 M 10.20 M
Shareholders' Equity 1.41 M -8.83 M 3.28 M 542,388.0 -8.98 M
Total Debt — — — 113,130.0 113,130.0
Cash & Equivalents 1.67 M 897,680.0 8.95 M 5.43 M 93,711.0
Current Assets 2.23 M 1.82 M 9.25 M 5.72 M 196,711.0
Current Liabilities 826,764.0 7.92 M 3.36 M 2.40 M 7.20 M